Recursion Pharmaceuticals

OpenAI researcher Miles Wang is in talks to launch an AI drug discovery startup at a $2 billion pre-money valuation, with Lightspeed Venture Partners in discussions to lead a ~$200 million round. The …

MindWalk Holdings, trading as HYFT on NASDAQ, filed a European patent for its high-dimensional biological data architecture, signaling a strategic pivot as AI models become commoditized. The patent ap…

Astromech, a startup founded in 2025 by Ben Lamm and George Church, develops a Large Life Model and autonomous biological intelligence system that fuses evolutionary logic with deep learning to decode…